Tom DiLenge

@TomDilenge

Helping biotech companies heal, fuel & feed the world as Pres. of Advocacy, Law & Public Policy. fan. aficionado. Husband, Dad to 3

Washington, D.C.
Vrijeme pridruživanja: srpanj 2015.

Tweetovi

Blokirali ste korisnika/cu @TomDilenge

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @TomDilenge

  1. Prikvačeni tweet
    17. sij

    I get up in the morning to fight for smart policies that improve millions of lives--and just as says in this article--by making ill-advised policy changes, "patients [may] fall into the cracks, sometimes paying with their lives."

    Poništi
  2. prije 13 sati

    Say it ain’t so—I’m stricken with sadness at the thought of being without the *most secure* on planet Earth. I’ve been a loyal customer since the beginning—I’m never giving up my ! | via

    Poništi
  3. proslijedio/la je Tweet
    3. velj

    Next season starts now. Welcome aboard Flight 2020.

    Poništi
  4. proslijedio/la je Tweet
    1. velj

    An urgent reminder of what is at stake, as misguided policies on threaten to disable world-leading US .

    Poništi
  5. proslijedio/la je Tweet
    30. sij

    BREAKING NEWS: NORD joins 26 other patient orgs in opposing guidance released today on block grant funding of that will reduce access to quality and affordable health care for patients. . Read more:

    Poništi
  6. 31. sij

    I'm proud to announce that released our 1st annual report on in . BIO is committed to helping companies grow diversity in our industry because the . Get the full report & more info on BIO’s related efforts at

    Poništi
  7. 31. sij

    leader Rachel King urges to reject foreign , saying "if we decrease the incentives for investing in new drugs, the money will flow out of the biotechnology industry” & we'll risk losing a generation of new

    Poništi
  8. proslijedio/la je Tweet
    30. sij

    “Any reform that deprives patients of new treatments for Alzheimer's, Parkinson's, ALS, cancer, and other debilitating diseases … deserves to be rejected out-of-hand.” More from in on the impact of adopting foreign price controls.

    Poništi
  9. 29. sij

    This illustrates how high costs for are largely a function of deliberate and discriminatory insurance benefit design—bad for patients, increases system costs. Congrats to for making this long overdue move! Via

    Poništi
  10. 24. sij

    Great to see Deerfield make a big infrastructure investment for the ecosystem to support commercialization of cell and gene therapies in ! |

    Poništi
  11. proslijedio/la je Tweet
    23. sij

    Thanks for sharing, -- this is a dangerous myth that continues to be debunked.

    Poništi
  12. 22. sij

    Great example from that illustrates how the rebate system creates perverse incentives for plans. These benefit designs are negatively impacting ' out-of-pocket costs for needed medicines

    Poništi
  13. 22. sij

    An overlooked nugget in this report: The drop in deaths are attributed to several factors, including the innovative therapies for metastatic of the skin that led to a 5-7% reduction in adult deaths/year | via

    Poništi
  14. 22. sij

    BIO’s CEO talks about the failure of Achaogen's novel antibiotic as an illustration of the stark reality and risky endeavor our industry faces in an uncertain reimbursement environment | via

    Poništi
  15. 21. sij

    In this editorial, illustrates the rollercoaster of innovative successes and failures from 2019 juxtaposed against the policy challenges facing the industry in 2020: via

    Poništi
  16. 18. sij

    What a comeback! We were down 4-1 in the 3rd and scored 5 unanswered to win!

    Poništi
  17. 17. sij

    Looks like it's going to be another exciting spring to be a fan!

    Poništi
  18. 17. sij

    I'm excited to participate with and on January 22nd at the Transformation of Public Affairs Workshop to discuss the biggest public policy issues in 2020 and beyond. Register here to engage in the conversation:

    Poništi
  19. 17. sij

    Great to see the taking these steps--hopefully more competition will help mitigate the skyrocketing that now account for 33% of total spending according the latest report:

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·